GB9215921D0 - Anti-inflammatory compounds - Google Patents

Anti-inflammatory compounds

Info

Publication number
GB9215921D0
GB9215921D0 GB929215921A GB9215921A GB9215921D0 GB 9215921 D0 GB9215921 D0 GB 9215921D0 GB 929215921 A GB929215921 A GB 929215921A GB 9215921 A GB9215921 A GB 9215921A GB 9215921 D0 GB9215921 D0 GB 9215921D0
Authority
GB
United Kingdom
Prior art keywords
inflammatory compounds
inflammatory
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929215921A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB929215921A priority Critical patent/GB9215921D0/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of GB9215921D0 publication Critical patent/GB9215921D0/en
Priority to IL106472A priority patent/IL106472A0/xx
Priority to TW082105933A priority patent/TW246670B/zh
Priority to ZA935378A priority patent/ZA935378B/xx
Priority to MX9304503A priority patent/MX9304503A/es
Priority to CA002141214A priority patent/CA2141214A1/en
Priority to AU47170/93A priority patent/AU672810B2/en
Priority to JP6504325A priority patent/JPH07509462A/ja
Priority to EP93917925A priority patent/EP0652864A1/en
Priority to PCT/GB1993/001585 priority patent/WO1994002448A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB929215921A 1992-07-27 1992-07-27 Anti-inflammatory compounds Pending GB9215921D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GB929215921A GB9215921D0 (en) 1992-07-27 1992-07-27 Anti-inflammatory compounds
IL106472A IL106472A0 (en) 1992-07-27 1993-07-26 Hydroxamic acid derivatives,their preparation and pharmaceutical compositions containing them
TW082105933A TW246670B (enExample) 1992-07-27 1993-07-26
ZA935378A ZA935378B (en) 1992-07-27 1993-07-26 Anti-inflammatory compounds
MX9304503A MX9304503A (es) 1992-07-27 1993-07-26 Compuestos antiinflamatorios.
CA002141214A CA2141214A1 (en) 1992-07-27 1993-07-27 Hydroxamic acid derivatives and their use as anti-inflammatory compounds
PCT/GB1993/001585 WO1994002448A1 (en) 1992-07-27 1993-07-27 Hydroxamic acid derivatives and their use as anti-inflammatory compounds
AU47170/93A AU672810B2 (en) 1992-07-27 1993-07-27 Hydroxamic acid derivatives and their use as anti-inflammatory compounds
JP6504325A JPH07509462A (ja) 1992-07-27 1993-07-27 ヒドロキサム酸誘導体および抗炎症化合物としてのこれらの使用
EP93917925A EP0652864A1 (en) 1992-07-27 1993-07-27 Hydroxamic acid derivatives and their use as anti-inflammatory compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929215921A GB9215921D0 (en) 1992-07-27 1992-07-27 Anti-inflammatory compounds

Publications (1)

Publication Number Publication Date
GB9215921D0 true GB9215921D0 (en) 1992-09-09

Family

ID=10719360

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929215921A Pending GB9215921D0 (en) 1992-07-27 1992-07-27 Anti-inflammatory compounds

Country Status (10)

Country Link
EP (1) EP0652864A1 (enExample)
JP (1) JPH07509462A (enExample)
AU (1) AU672810B2 (enExample)
CA (1) CA2141214A1 (enExample)
GB (1) GB9215921D0 (enExample)
IL (1) IL106472A0 (enExample)
MX (1) MX9304503A (enExample)
TW (1) TW246670B (enExample)
WO (1) WO1994002448A1 (enExample)
ZA (1) ZA935378B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL314605A1 (en) * 1993-11-26 1996-09-16 Pfizer Isoxazolin compounds as anti-inflammatory agents
EP0749307A1 (en) * 1994-03-09 1996-12-27 Pfizer Inc. Isoxazoline compounds as 5-lipoxygenase inhibitors
CA2210905A1 (en) * 1995-02-02 1996-08-08 Nikken Chemicals Co., Ltd. N-hydroxyurea derivatives
ES2243978T3 (es) 1996-02-13 2005-12-01 G.D. SEARLE & CO. Composiciones que comprenden un inhibidor de la ciclooxigenasa-2 y un antagonista del receptor de leucotrieno b4.
CA2246265A1 (en) 1996-02-13 1997-08-21 G.D. Searle & Co. Combinations having immunosuppressive effects, containing cyclooxygenase-2-inhibitors and 5-lipoxygenase inhibitors
PT880363E (pt) 1996-02-13 2002-12-31 Searle & Co Combinacoes com efeitos imunossupressores cntendo um inibidor da ciclooxigenase-2 e um inibidor da hidrolase do leucotrieno a4
US6184217B1 (en) * 1996-06-25 2001-02-06 Cephalon, Inc. Use of K-252a derivative
NZ501166A (en) * 1997-07-31 2001-12-21 Abbott Lab Reverse hydroxamate-containing compounds and their use as inhibitors of matrix metalloproteinases
US6294573B1 (en) 1997-08-06 2001-09-25 Abbott Laboratories Reverse hydroxamate inhibitors of matrix metalloproteinases
US6235786B1 (en) 1997-08-06 2001-05-22 Abbott Laboratories Reverse hydroxamate inhibitors of matrix metalloproteinases
US6288261B1 (en) 1998-12-18 2001-09-11 Abbott Laboratories Inhibitors of matrix metalloproteinases
WO2000044712A1 (en) * 1999-01-27 2000-08-03 Abbott Laboratories N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
SE0103325D0 (sv) * 2001-10-04 2001-10-04 Astrazeneca Ab Novel compounds
US8476305B2 (en) 2008-02-07 2013-07-02 Kyorin Pharmaceutical Co., Ltd. Therapeutic agent or prophylactic agent for inflammatory bowel disease comprising amino alcohol derivative as active ingredient

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201300B (en) * 1985-03-16 1990-10-28 Wellcome Found Process for production of derivatives of aryl and medical compositions containing them as active substance
PL154186B1 (en) * 1987-07-15 1991-07-31 Wellcome Found Method for manufacturing arylic derivatives of the hydroxamic acid
JPH0819069B2 (ja) * 1990-07-25 1996-02-28 アボツト・ラボラトリーズ リポキシゲナーゼ阻害活性を有するアセチレン誘導体
JPH06256285A (ja) * 1990-12-11 1994-09-13 Pfizer Pharmaceut Co Ltd ヒドロキサム酸誘導体およびその用途

Also Published As

Publication number Publication date
AU4717093A (en) 1994-02-14
WO1994002448A1 (en) 1994-02-03
JPH07509462A (ja) 1995-10-19
MX9304503A (es) 1994-04-29
CA2141214A1 (en) 1994-02-03
EP0652864A1 (en) 1995-05-17
AU672810B2 (en) 1996-10-17
ZA935378B (en) 1995-01-26
IL106472A0 (en) 1993-11-15
TW246670B (enExample) 1995-05-01

Similar Documents

Publication Publication Date Title
AP9300508A0 (en) Compounds
GB9200245D0 (en) Compounds
GB9201755D0 (en) Compounds
GB9200210D0 (en) Compounds
GB9201694D0 (en) Compounds
GB9201693D0 (en) Compounds
GB9200209D0 (en) Compounds
GB9215921D0 (en) Anti-inflammatory compounds
GB9200566D0 (en) Compounds
GB9201751D0 (en) Compounds
GB9202792D0 (en) Compounds
GB9201692D0 (en) Compounds
GB9308652D0 (en) Anti-inflammatory compounds
GB9223161D0 (en) Anti-inflammatory compounds
GB9216682D0 (en) Anti-inflammatory compounds
GB9203512D0 (en) Anti-inflammatory compounds
GB9318432D0 (en) Anti-inflammatory compounds
GB9119554D0 (en) Anti-inflammatory compounds
GB9203919D0 (en) Pharmaceutical anti-inflammatory compounds
GB9203175D0 (en) Compounds
GB9203173D0 (en) Compounds
GB9203177D0 (en) Compounds
GB9203176D0 (en) Compounds
GB9202991D0 (en) Compounds
GB9201747D0 (en) Compounds